Delivery Order SPE2DB20D3103-SPE2DB23FL8C8

Award Date 12/7/22
Potential Completion Date 12/8/22
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,027.34 firm fixed-price delivery order is for the supply of hydrocortisone ointment, which supports federal healthcare programs. The award is associated with Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.27 firm fixed-price delivery order is for the supply of 453.6 grams of 2.5% hydrocortisone ointment. The contract has a period of performance through March 4, 2025 and was not designated as a set-aside procurement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of 4558536306 - Hydrocortisone Val 0.2% Ointment 45GM. The $4,866.24 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 21, 2022. The contract is not designated as a set-aside and represents delivery order work under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563681465 - Hydrocortisone Val 0.2% Ointment, 15 gm, with a ceiling value of $2,618. It is a firm fixed price delivery order contract with a completion date of February 16, 2024. The award was made on February 15, 2024, and there was no set-aside designation. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,874.14, is for the delivery of 15 gram tubes of 0.2% hydrocortisone ointment. The contract has an ultimate completion date of December 14, 2023 and is a firm fixed price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.43 contract is for the delivery of 45-gram tubes of 0.2% hydrocortisone ointment. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a wide range of pharmaceutical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.85 firm-fixed-price contract is for the delivery of 4556497960 - Hydrocortisone Valerate 0.2% Ointment, 45g tubes. The award has no set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which serves as a critical...
This federal contract award (SPE2DB20D3505|SPE2DB24FU8C0) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,577.72 firm fixed-price delivery order is for the supply of 4565454980 - Hydrocortisone Valerate 0.2% Ointment, 15g. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60 gram tubes of 0.2% hydrocortisone ointment. The contract has a ceiling value of $6,242.14 and runs through May 17, 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through November...
This award is a delivery order under contract SPE2DB22D1017 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 60 gram tubes of 0.2% hydrocortisone ointment. The $1,224.05 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of September 29, 2023. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FL8C8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,204.70 firm fixed-price delivery order is for the supply of 4559301259 - Hydrocortisone Val 0.2% Ointment 45GM. No set-aside was used for this award.

The award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 1:17 PM